A detailed history of Cary Street Partners Investment Advisory LLC transactions in Zomedica Corp. stock. As of the latest transaction made, Cary Street Partners Investment Advisory LLC holds 10,300 shares of ZOM stock, worth $1,339. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,300
Previous 10,300 -0.0%
Holding current value
$1,339
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

BUY
$0.15 - $0.22 $1,545 - $2,266
10,300 New
10,300 $2,000
Q3 2022

Nov 14, 2022

BUY
$0.2 - $0.38 $2,060 - $3,914
10,300 New
10,300 $2,000

Others Institutions Holding ZOM

About Zomedica Corp.


  • Ticker ZOM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 979,950,016
  • Market Cap $127M
  • Description
  • Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...
More about ZOM
Track This Portfolio

Track Cary Street Partners Investment Advisory LLC Portfolio

Follow Cary Street Partners Investment Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.